Skip to main content
OpenTrials
Completed

NCT Number: NCT04505228

The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia

72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The research group received regular medication against hypertension and the personalized formulas based on syndrome differentiation, meanwhile the control group only received the regular medication. The five symptoms (palpitation, short of breath, angina, dizzy and lumbar debility) were graded and used for evaluation of treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertensive Heart Disease

Age range

20 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The fifth Qingdao people's hospital

Qingdao, Shandong, 266000, China

About this study

To test the effect of Chinese herb against the hypertensive heart disease, we designed this randomized controlled clinical trial. 72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The five symptoms (palpitation, short of breath, angina, dizzy and lumbar debility) were graded. The research group received regular medication against hypertension and the personalized formulas based on syndrome differentiation, meanwhile the control group only received the regular medication. 2 weeks after treatment, all the symptoms were graded again.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of hypertensive bradyarhhythmia

Exclusion criteria

  • With other elementary diseases
  • With pregnant
  • With receiving other treatment within past half year from the beginning of trial.

Treatment and study plan

Safflower (Carthamus Tinctorius) IgG4 | Serum | Allergy

Drug

The designed Chinese herb formulas

Other names: Xuefuzhuyu

Atropine Sulfate

Drug

The basic treatment for heart disease

Primary outcomes

  1. typical symptoms in patients with hypertensive bradyarrhythmia

    Time frame: 2 weeks

    The five indexes of typical symptoms in patients with hypertensive bradyarrhythmia (palpitation, angina, shortness of breath, dizzy, lumbar debility) were evaluated and scored both before treatment and after treatment according to "Guiding principles for clinical research of new Chinese Medicine".

Sponsors and collaborators

Lead sponsor

Jun Xiao

Other

Collaborators

  • Qingdao Fifth People's Hospital

Registry information

Official study title

The Personalized Chinese Herb Formulas Are Evaluated for Their Effectiveness to Relieve Symptoms in Hypertensive Bradyarrhythmia

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Aug 10, 2020
Registry last updated
Aug 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.